As a conference track of ISMB, CAMDA focuses on one of the grand challenges of our time, the intelligent exploitation of Big Data in the Life Sciences. In the post genomic era, an effective scientific interpretation of large datasets is key to new medical and biological insights from novel high throughput assays and the increasing size of biomedical studies. CAMDA puts a spotlight on the successful analysis and integration of the massive data sets now prevalent in the life sciences.
This year, the scientific committee of CAMDA has set three data analysis contest challenges:
- MetaSUB Forensics Challenge presents hundreds of novel city microbiome profiles. Construct urban microbiome fingerprints and identify the geographical origin of mystery samples.
- CMap Drug Safety Challenge presents clinical toxicity results and gene expression responses to hundreds of drugs. Compare or integrate responses of multiple cell lines, predict drug induced liver injury in humans. Opt into an FDA meta-analysis.
- The Cancer Data Integration Challenge presents clinical data, RNA-seq and microarray gene expression, and CNV from aCGH. Demonstrate a robust analysis approach improving the state of the art for both Breast Cancer and Neuroblastoma.
Leading scientists present their best methods and analyses. Extended papers are then published in the open access, fully indexed conference proceedings at Biology Direct. Related method papers can enter the ISMB proceedings track of the Bioinformatics journal.
In the open-ended contest, all delegates vote for the best contributed analysis. The top three presenters win a free one-year subscription to F1000Prime (worth $250) and a free submission to F1000Research (worth $1000). The first prize in addition is awarded the prestigious CAMDA Trophy.
We cordially invite you to attend and contribute to CAMDA, and look forward to seeing you in Chicago!
(Travel fellowships available)
For the Programme Committee,
Joaquin Dopazo (Ministry of Health, Seville), David Kreil (Boku University Vienna), Pawel Labaj (Austrian Academy of Sciences), Weida Tong (US FDA), Diane Kovats (ISCB), and Wenzhong Xiao (Stanford & Harvard Medical School)
- Call for contributions -- now open
- Submissions to the ISMB proceedings track -- 29 January
- Registration of Intention to submit to the CAMDA proceedings track -- 05 April
- Opt into the FDA meta-analysis -- 15 April
- Submissions of CAMDA Extended Abstracts -- 13 May
- Acceptance decisions -- 20 May
- CAMDA Track at ISMB -- 07-08 July
- ISMB 2018 -- 06-10 July
- Submissions of full research papers to the CAMDA Proceedings -- 30 September